References
- Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A, Tremblay R. Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. Aging Male 2007; 10: 57–65
- Jankowska E, Bartosz B, Majda J, Szklarska A, Lopuszanska M, Medras M, Anker S D, Banasiak W, Poole-Wilson P A, Ponikowski P. Anabolic deficiency in men withchronic heart failure; prevalence and detremental impact on survival. Circulation 2006; 114: 1829–1837
- Cohen P G. Aromatase, adiposity, aging and disease–the hypogonadal-metabolic-atherogenic-disease and aging connection. Med Hypotheses 2001; 56: 702–708
- Valenti G. Frailty as a dysruption of steroid ‘syncrinology’ in elderly man. Acta Biomed 2007; 78(Suppl.1)222–224
- Cohen P G. The hypogonadal-obesity cycle: the role of aromatase in modulating the testosterone-estradiol shunt–a major factor in the genesis of morbid obesity. Med Hypotheses 1999; 52: 49–51